Efficacy and tolerability of treatment with single doses of diethylcarbamazine (DEC) and DEC plus albendazole (ABZ) for three consecutive years in lymphatic filariasis: a field study in India

[1]  Mark S. Schmidt,et al.  Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Stensgaard,et al.  Lymphatic filariasis control in Tanga Region, Tanzania: status after eight rounds of mass drug administration , 2014, Parasites & Vectors.

[3]  S. Njenga,et al.  Evaluation of effectiveness of diethylcarbamazine/albendazole combination in reduction of Wuchereria bancrofti infection using multiple infection parameters. , 2011, Acta tropica.

[4]  S. Njenga,et al.  Sustained reduction in prevalence of lymphatic filariasis infection in spite of missed rounds of mass drug administration in an area under mosquito nets for malaria control , 2011, Parasites & Vectors.

[5]  W. Shannon,et al.  The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. , 2007, The American journal of tropical medicine and hygiene.

[6]  S. Weerasekara,et al.  Social mobilisation, drug coverage and compliance and adverse reactions in a Mass Drug Administration (MDA) Programme for the Elimination of Lymphatic Filariasis in Sri Lanka , 2007, Filaria journal.

[7]  J. Rizzo,et al.  Children and adolescents infected with Wuchereria bancrofti in Greater Recife, Brazil: a randomized, year-long clinical trial of single treatments with diethylcarbamazine or diethylcarbamazine–albendazole , 2007, Annals of tropical medicine and parasitology.

[8]  N. Karunaweera,et al.  Impact of the 2004 mass drug administration for the control of lymphatic filariasis, in urban and rural areas of the Western province of Sri Lanka , 2007, Annals of tropical medicine and parasitology.

[9]  K. Ramaiah,et al.  Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine. , 2007, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  A. Bhumiratana,et al.  Adverse reactions of 300 MG diethylcarbamazine, and in a combination of 400 MG albendazole, for a mass annual single dose treatment, in migrant workers in Phang Nga province. , 2007, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[11]  P. Leggat,et al.  Qualitative analysis of the impact of a lymphatic filariasis elimination programme using mass drug administration on Misima Island, Papua New Guinea , 2007, Filaria journal.

[12]  M. Alpers,et al.  Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. , 2007, The American journal of tropical medicine and hygiene.

[13]  D. Addiss,et al.  Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[14]  A. Dash,et al.  Impact of single dose of diethylcarbamazine and other antifilarial drug combinations on bancroftian filarial infection variables: assessment after 2 years. , 2006, Parasitology international.

[15]  A. Bhumiratana,et al.  Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand. , 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[16]  G. Weil,et al.  Bancroftian filariasis: effect of repeated treatment with diethylcarbamazine and albendazole on microfilaraemia, antigenaemia and antifilarial antibodies. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  A. Dash,et al.  Community‐based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India , 2006, Tropical medicine & international health : TM & IH.

[18]  A. S. Kerketta,et al.  Adverse reactions following mass drug administration during the Programme to Eliminate Lymphatic Filariasis in Orissa State, India. , 2006, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[19]  W. Shannon,et al.  Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment , 2006, The Lancet.

[20]  G. Taleo,et al.  Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach. , 2005, The American journal of tropical medicine and hygiene.

[21]  D. Meyrowitsch,et al.  The effect of eight half-yearly single-dose treatments with DEC on Wuchereria bancrofti circulating antigenaemia. , 2005, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[22]  P. Vanamail,et al.  Tolerability and efficacy of a three-age class dosage schedule of Diethylcarbamazine citrate (DEC) in the treatment of microfilaria carriers of Wuchereria bancrofti and its implications in mass drug administration (MDA) strategy for elimination of lymphatic filariasis (LF). , 2005, The Journal of communicable diseases.

[23]  Michael J Beach,et al.  Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence , 2004, Filaria journal.

[24]  N. Gogtay,et al.  Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. , 2004, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[25]  G. Weil,et al.  A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis. , 2004, The American journal of tropical medicine and hygiene.

[26]  A. Bhumiratana,et al.  Wuchereria bancrofti antigenemia clearance among Myanmar migrants after biannual mass treatments with diethylcarbamazine, 300 mg oral-dose FILADEC tablet, in Southern Thailand. , 2003, The Southeast Asian journal of tropical medicine and public health.

[27]  K. Ramaiah,et al.  The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets , 2003, Annals of tropical medicine and parasitology.

[28]  Azura,et al.  Mass Treatment to Eliminate Filariasis in Papua New Guinea , 2002 .

[29]  D. Addiss,et al.  Evaluation of the whole blood filariasis ICT test for short-term monitoring after antifilarial treatment. , 2000, The American journal of tropical medicine and hygiene.

[30]  R. B. Narayanan,et al.  Quantitative assessment of circulating antigens in human lymphatic filariasis: a field evaluation of monoclonal antibody‐based ELISA using blood collected on filter strips , 1998, Tropical medicine & international health : TM & IH.

[31]  G. Weil,et al.  Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis. , 1998, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[32]  A. Hightower,et al.  Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin. , 1997, The American journal of tropical medicine and hygiene.

[33]  A. Hightower,et al.  Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children , 1997, The Lancet.